Zimmer Biomet Holdings, Inc. (ZBH)

Market Cap	18.60B
Revenue (ttm)	7.70B
Net Income (ttm)	913.40M
Shares Out	197.85M
EPS (ttm)	4.51
PE Ratio	20.86
Forward PE	11.73
Dividend	$0.96 (1.02%)
Ex-Dividend Date	Jun 26, 2025

Volume	2,335,012
Open	95.95
Previous Close	93.86
Day's Range	93.25 - 95.95
52-Week Range	89.22 - 116.71
Beta	0.71
Analysts	Hold
Price Target	112.74 (+19.9%)
Earnings Date	Aug 7, 2025

About ZBH

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open hear...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1927
• Employees: 17,000
• Stock Exchange: NYSE
• Ticker Symbol: ZBH
• Website: https://www.zimmerbiomet.com

Financial Performance

In 2024, Zimmer Biomet Holdings's revenue was $7.68 billion, an increase of 3.85% compared to the previous year's $7.39 billion. Earnings were $903.80 million, a decrease of -11.74%.

Analyst Summary

According to 21 analysts, the average rating for ZBH stock is "Hold." The 12-month stock price target is $112.74, which is an increase of 19.90% from the latest price.

Price Target

$112.74

(19.90% upside)

Analyst Consensus: Hold